Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16576 - 16600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cholic Acid	Approved Investigational	ABCC3	8714	upregulated	Cholic Acid results in increased expression of ABCC3 mRNA	17q21.33	A21591
Cholic Acid	Approved Investigational	ABCG5	64240	upregulated	Cholic Acid results in increased expression of ABCG5 mRNA	2p21	A21591
Cholic Acid	Approved Investigational	CYP7A1	1581	downregulated	Cholic Acid results in decreased expression of CYP7A1 mRNA	8q12.1	A21591
Cholic Acid	Approved Investigational	CYP8B1	1582	downregulated	Cholic Acid results in decreased expression of CYP8B1 mRNA	3p22.1	A21591
Cholic Acid	Approved Investigational	FGF19	9965	upregulated	Cholic Acid results in increased expression of FGF19 mRNA	11q13.3	A21591
Cholic Acid	Approved Investigational	GPBAR1	151306	upregulated	Cholic Acid results in increased expression of GPBAR1 mRNA	2q35	A21591
Cholic Acid	Approved Investigational	NR0B2	8431	upregulated	Cholic Acid results in increased expression of NR0B2 mRNA	1p36.11	A21591
Cholic Acid	Approved Investigational	NR1H4	9971	upregulated	Cholic Acid results in increased expression of NR1H4 mRNA	12q23.1	A21591
Cholic Acid	Approved Investigational	SLC10A1	6554	downregulated	Cholic Acid results in decreased expression of SLC10A1 mRNA	14q24.1	A21591
Cholic Acid	Approved Investigational	SLC51A	200931	upregulated	Cholic Acid results in increased expression of SLC51A mRNA	3q29	A21591
Cholic Acid	Approved Investigational	SLC51B	123264	upregulated	Cholic Acid results in increased expression of SLC51B mRNA	15q22.31	A21591
Cholic Acid	Approved Investigational	SLCO1B3	28234	upregulated	Cholic Acid results in increased expression of SLCO1B3 mRNA	12p12.2	A21591
Choline	Approved Investigational Nutraceutical	PPARGC1A	10891	upregulated	Choline results in increased expression of PPARGC1A mRNA	4p15.2	A20470
Chondroitin sulfate	Approved Investigational Nutraceutical	TNFSF11	8600	downregulated	Chondroitin Sulfates results in decreased expression of TNFSF11 mRNA	13q14	A21639
Chromium	Approved Investigational	ABCA1	19	upregulated	Chromium results in increased expression of ABCA1 mRNA	9q31.1	A21640
Chromium	Approved Investigational	ABCG2	9429	upregulated	Chromium results in increased expression of ABCG2 mRNA	4q22.1	A20678
Chromium	Approved Investigational	ABI3BP	25890	downregulated	Chromium results in decreased expression of ABI3BP mRNA	3q12.2	A21641
Chromium	Approved Investigational	ACP2	53	downregulated	Chromium results in decreased expression of ACP2 mRNA	11p11.2	A20678
Chromium	Approved Investigational	ACSL1	2180	downregulated	Chromium results in decreased expression of ACSL1 mRNA	4q35.1	A20678
Chromium	Approved Investigational	ADAMTS1	9510	upregulated	Chromium results in increased expression of ADAMTS1 mRNA	21q21.3	A21641
Chromium	Approved Investigational	ADAMTS5	11096	upregulated	Chromium results in increased expression of ADAMTS5 mRNA	21q21.3	A21641
Chromium	Approved Investigational	ADGRL2	23266	downregulated	Chromium results in decreased expression of ADGRL2 mRNA	1p31.1	A21641
Chromium	Approved Investigational	ADM	133	upregulated	Chromium results in increased expression of ADM mRNA	11p15.4	A20678
Chromium	Approved Investigational	AKR1B1	231	downregulated	Chromium results in decreased expression of AKR1B1 mRNA	7q33	A20678
Chromium	Approved Investigational	ANXA2	302	upregulated	Chromium results in increased expression of ANXA2 mRNA	15q22.2	A20678

Displaying entries 16576 - 16600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability